Risankizumab
Generic Name: risankizumab
Dosage form: INJECTION, SOLUTION. Active ingredients: RISANKIZUMAB (600 mg/10mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION, SOLUTION. Active ingredients: RISANKIZUMAB (600 mg/10mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection, solution.
Related Medications
Brassica Oleracea Var. Botrytis
brassica oleracea var. botrytis
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: BROCCOLI (.025 g/mL). Category: BLA.
Butal/apap/caff
butal/apap/caff
Barbiturate [EPC]
Butalbital, Acetaminophen, and Caffeine Tablets, USP are supplied in tablet form for oral administration. Each tablet contains the following active ingredients: Butalbital, USP . . . . . . . . . .50 mg Acetaminophen, USP . . . . .325 mg Caffeine, USP . . . . . . . . . . .40 mg Inactive Ingredients: microcrystalline cellulose, crospovidone, croscarmellose sodium, corn starch, stearic acid, colloidal silicon dioxide, magnesium stearate, and FD&C Blue No. 1.
Tizandine
tizandine
Tizanidine hydrochloride is a central alpha2-adrenergic agonist. Tizanidine hydrochloride, USP is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in water and methanol; solubility in water decreases as the pH increases. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole monohydrochloride.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.